-
Our Mission: Improving theQuality of
Sarcoma Patient Care -
The Swiss Sarcoma Network is aninterdisciplinary Platform
of sarcoma experts -
Specialists across disciplinesrepresent the Swiss Sarcoma Board
Home
Our Mission: Quality for sacroma patients
The main goal of the SwissSarcomaNetwork (SSN) is to improve and ensure the quality of sarcoma patient care in Switzerland.
- We collaborate multi-institutionally.
- We strengthen sarcoma competence in Switzerland.
- We establish diagnostic and clinical pathways.
- We maintain a prospective sarcoma database (registry) with real-time data analysis visualization.
- We establish a quality assurance system.
- We introduce a value based health care system.
Our Members
The International Advisory Board
To provide excellent quality of sarcoma patient care in Switzerland, the SwissSarcomaNetwork (SSN) collaborates on an international level, and established the International Advisory Board comprising world-renowned experts in the sarcoma discipline:
Prof. Axel Le Cesne, France, Coordinator of the International Advisory Board of the SSNProf. Jean-Yves Blay, France
Prof. Javier Martin-Broto, Spain
Prof. Alessandro Gronchi, Italy
Find out more about the International Advisory Board
For Patients
Please visit www.sarkom-schweiz.ch to get all the information you need (available in German and French).
Honors / Prizes
CSS QUALITY CRISTAL AWARD 2022
As the largest health insurer in Switzerland, CSS has been honoring quality-conscious and innovative players in the health care sector since 2014. The award-winning institutions and their projects consistently focus on patients and act in a particularly quality-conscious manner in their day-to-day work. The SwissSarcomaNetwork (SSN) was awarded in the special prize category Coordinated Innovative Healthcare. The network established in a multi-institutional setting quality indicators for the complex care of a rare disease, namely sarcoma. An interoperable digital platform with consecutive and longitudinal real-life data is used to include clinical physcian-based data as well as “Patient Reported Outcome Measures” (PROMS). These record how a patient assesses their own state of health. The SSN is now able to collect multi-institutional structured quality data of sarcoma care, subjecting them to evidence analytics and thereby paving the way to precision medicine.
GERMAN MEDICAL AWARD 2021
The German Medical Award (GMA) is the most important medical award in Germany. With the GMA, outstanding performance in quality and transparency is made clear year after year and patients are shown where they can expect optimal care services at the highest professional and human level. The SSN wins this presitgious award in the category «Medical Research: Future Digital Medicine». They present an interoperable digital platform which allows the real-time collection of physician- and patient-based structured data of sarcoma quality care. Such digital real-time-world data platform allows the interoperability of harmonized data exchange between institutions globally, allows the transparent comparison of quality of care and thereby even an international benchmark. Because data are structured, real-time evidence analytics is possible, paving the way for precision medicine and ultimately, the creation of the human digital twin.
